BIOTECH EXPERIENCE & AFFILIATIONS

BIOTECH EXPERIENCE & AFFILIATIONS

Advanced numerous public health interventions to reduce disease burden and protect against chronic and infectious diseases and environmental threats, as well as several first-in-class genetically engineered commercial products.
Advanced numerous public health interventions to reduce disease burden and protect against chronic and infectious diseases and environmental threats, as well as several first-in-class genetically engineered commercial products.
TECHNOLOGY & BUSINESS STRATEGY
TECHNOLOGY & BUSINESS STRATEGY
  • Served as technology analyst and business strategist at pioneering publicly-traded synthetic biology and genetic engineering company Intrexon, advising C-suite and FORBES 400 largest individual American biotech investor across health, food, consumer, biosecurity, and environment sectors (Intrexon)
  • Helped establish environment sector focused on leveraging synthetic biology and genetic engineering for infectious disease vector control, biosecurity, and bioremediation of environmental contaminants of concern (Intrexon)
  • Led internal, external, and open innovation functions to advance new product development and collaborations for large publicly traded multi-national biotechnology company (Intrexon)
  • Marketed and advanced several FDA, USDA, and EPA regulated first-in-class gene-edited and genetically engineered (GE) organisms for food, environmental, and public health applications (GE fish, GE fruit, GE insects, GE microbes), as well as animal cloning technologies (Intrexon)
  • Supported diligence and business strategy for biotechnology acquisitions exceeding $400M (Intrexon) (see list)
  • Served as technology analyst and business strategist at pioneering publicly-traded synthetic biology and genetic engineering company Intrexon, advising C-suite and FORBES 400 largest individual American biotech investor across health, food, consumer, biosecurity, and environment sectors (Intrexon)
  • Helped establish environment sector focused on leveraging synthetic biology and genetic engineering for infectious disease vector control, biosecurity, and bioremediation of environmental contaminants of concern (Intrexon)
  • Led internal, external, and open innovation functions to advance new product development and collaborations for large publicly traded multi-national biotechnology company (Intrexon)
  • Marketed and advanced several FDA, USDA, and EPA regulated first-in-class gene-edited and genetically engineered (GE) organisms for food, environmental, and public health applications (GE fish, GE fruit, GE insects, GE microbes), as well as animal cloning technologies (Intrexon)
  • Supported diligence and business strategy for biotechnology acquisitions exceeding $400M (Intrexon) (see list)
BIOTECHNOLOGY DEVELOPMENT & COMMERCIALIZATION
BIOTECHNOLOGY DEVELOPMENT & COMMERCIALIZATION
  • Developed current FDA approved molecular tests to screen US blood supply for HIV, HCV, HBV, West Nile Virus (Gen-Probe)
  • Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined Chlamydia and Gonorrhea molecular tests (Gen-Probe)
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
  • Developed current FDA approved molecular tests to screen US blood supply for HIV, HCV, HBV, West Nile Virus (Gen-Probe)Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined Chlamydia and Gonorrhea molecular tests (Gen-Probe)
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
  • Developed current FDA approved molecular tests to screen US blood supply for HIV, HCV, HBV, West Nile Virus (Gen-Probe)
  • Launched the APTIMA infectious disease molecular diagnostic platform with the first FDA-cleared combined Chlamydia and Gonorrhea molecular tests (Gen-Probe)
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
PUBLIC HEALTH INNOVATION
PUBLIC HEALTH INNOVATION
  • Participated in transitioning safety testing of US blood supply from immunoassay to more sensitive molecular testing platform in use today (Gen-Probe)
  • Developed biodefense and threat detection systems against bioterrorism agents and infectious diseases for US Intelligence Community (Vectrant)
  • Facilitated protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, healthy air, and health education to reduce burden of chronic and infectious diseases (Central Region Malawi)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
  • Pioneered gene-edited bioremediation platform for environmental cleanup of contaminants-of-concern (Intrexon)
  • Participated in transitioning safety testing of US blood supply from immunoassay to more sensitive molecular testing platform in use today (Gen-Probe)
  • Developed biodefense and threat detection systems against bioterrorism agents and infectious diseases for US Intelligence Community (Vectrant)
  • Facilitated protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, healthy air, and health education to reduce burden of chronic and infectious diseases (Central Region Malawi)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
  • Pioneered gene-edited bioremediation platform for environmental cleanup of contaminants of concern (Intrexon)
  • Participated in transitioning safety testing of US blood supply from immunoassay to more sensitive molecular testing platform in use today (Gen-Probe)
  • Developed biodefense and threat detection systems against bioterrorism agents and infectious diseases for US Intelligence Community (Vectrant)
  • Facilitated protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, malaria, healthy air, and health education to reduce burden of chronic and infectious diseases (Central Region Malawi)
  • Advanced genetically engineered mosquitoes for use in mosquito-borne infectious disease vector control to reduce spread of Zika, dengue, yellow fever, chikungunya, and malaria (Intrexon, Oxitec)
  • Pioneered gene-edited bioremediation platform for environmental cleanup of contaminants of concern (Intrexon)
click to read more
  • Helped flatten the curve on epidemic STIs and infectious diseases with development of APTIMA molecular diagnostic platform (Gen-Probe)
  • Helped establish corporate environmental biotechnology strategy, public health, and One Health initiatives at pioneering synthetic biology company (Intrexon)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Developed biotechnologies with public health applications:
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Environmental health interventions for bioremediation of emerging contaminants of concern (COCs) (Intrexon)
  • Chronic disease diagnostic technologies for genetic and cancer biomarker profiling (Exonhit, Intrexon)
  • Marketed biotechnologies with public health applications:
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)
  • Helped flatten the curve on epidemic STIs and infectious diseases with development of APTIMA molecular diagnostic platform (Gen-Probe)
  • Helped establish corporate environmental biotechnology strategy, public health, and One Health initiatives at pioneering synthetic biology company (Intrexon)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Developed biotechnologies with public health applications:
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Environmental health interventions for bioremediation of emerging contaminants of concern (COCs) (Intrexon)
  • Chronic disease diagnostic technologies for genetic and cancer biomarker profiling (Exonhit, Intrexon)
  • Marketed biotechnologies with public health applications:
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)
  • Helped flatten the curve on epidemic STIs and infectious diseases with development of APTIMA molecular diagnostic platform (Gen-Probe)
  • Helped establish corporate environmental biotechnology strategy, public health, and One Health initiatives at pioneering synthetic biology company (Intrexon)
  • Engaged federal, state, and local government leaders and agencies, as well as briefed US Congress to advance high-profile new technologies for the public health (Intrexon)
  • Developed biotechnologies with public health applications:
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Environmental health interventions for bioremediation of emerging contaminants of concern (COCs) (Intrexon)
  • Chronic disease diagnostic technologies for genetic and cancer biomarker profiling (Exonhit, Intrexon)
  • Marketed biotechnologies with public health applications:
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)

FORMER AFFILIATIONS
FORMER AFFILIATIONS
COMPANIES
  • Intrexon | pioneering synthetic biology and genetic engineering company
  • Exonhit Therapeutics | microarray molecular diagnostics for chronic disease and genetic variant screening
  • Vectrant Technologies | biodefense threat detection systems and infectious disease medical diagnostics
  • Nanogen | microarray molecular diagnostics for chronic and infectious diseases
  • Gen-Probe | molecular tests for screening US blood supply and clinical diagnostics for infectious diseases
ACADEMIC RESEARCH INSTITUTIONS
  • George Mason University, Department of Global and Community Health | master of public health graduate studies in epidemiology (program pending completion)
  • Scripps Institution of Oceanography, Marine Biology Research Division | independent research: environmental and extremophilic microbiology applications for molecular tools, medicines, and bioremediation
  • The Scripps Research Institute, Department of Immunology | immunology basic research focused on virology, cancer, and Alzheimer's disease during undergraduate studies
  • University of California San Diego, Department of Biology | undergraduate studies in biology
VOLUNTEER ORGANIZATIONS
  • American Lung Association
  • St. Gabriel's Hospital - Lilongwe District, Malawi
COMPANIES
  • Intrexon | pioneering synthetic biology and genetic engineering company
  • Exonhit Therapeutics | microarray molecular diagnostics for chronic disease and genetic variant screening
  • Vectrant Technologies | biodefense threat detection systems and infectious disease medical diagnostics
  • Nanogen | microarray molecular diagnostics for chronic and infectious diseases
  • Gen-Probe | molecular tests for screening US blood supply and clinical diagnostics for infectious diseases
VOLUNTEER ORGANIZATIONS
  • American Lung Association
  • St. Gabriel's Hospital - Lilongwe District, Malawi
ACADEMIC RESEARCH INSTITUTIONS
  • George Mason University, Department of Global and Community Health | master of public health graduate studies in epidemiology (program pending completion)
  • Scripps Institution of Oceanography, Marine Biology Research Division | independent research: environmental and extremophilic microbiology applications for molecular tools, medicines, and bioremediation
  • The Scripps Research Institute, Department of Immunology | immunology basic research focused on virology, cancer, and Alzheimer's disease during undergraduate studies
  • University of California San Diego, Department of Biology | undergraduate studies in biology

BIOTECHNOLOGY DEVELOPMENT & INNOVATION
BIOTECHNOLOGY DEVELOPMENT & INNOVATION
EXPERTISE & BIOTECH EXPERIENCE
  • New Product Development and Commercialization
  • Technology Analysis
  • Corporate Development M&A Diligence
  • Business & Corporate Strategy
  • Marketing and Branding
  • Business Development
  • Strategic and Technical Communications
  • Basic and Applied Research
  • Public Health and Global Health Interventions
  • Government Relations
  • Not-for-Profit and Philanthropic Engagements
DEVELOPMENT EXPERIENCE:
HEALTH, BIOSECURITY & ENVIRONMENT
  • Medical diagnostics
  • Environmental biosecurity threat detection
  • Bioremediation and environmental cleanup of chemical contaminants of concern (COCs)
MARKETING EXPERIENCE:
HEALTH, FOOD, BIOSECURITY & ENVIRONMENT
  • Environmental biosecurity threat detection
  • Bioremediation and environmental cleanup of chemical contaminants of concern (COCs)
  • Infectious disease vector control using genetic engineering technologies
  • Vaccines and therapeutics
  • Sustainable food and protein production using gene editing and genetic engineering technologies
EXPERTISE & BIOTECH EXPERIENCE
  • New Product Development and Commercialization
  • Technology Analysis
  • Corporate Development M&A Diligence
  • Business & Corporate Strategy
  • Marketing and Branding
  • Business Development
  • Strategic and Technical Communications
  • Basic and Applied Research
  • Public Health and Global Health Interventions
  • Government Relations
  • Not-for-Profit and Philanthropic Engagements
DEVELOPMENT EXPERIENCE: HEALTH, BIOSECURITY & ENVIRONMENT
  • Medical diagnostics
  • Environmental biosecurity threat detection
  • Bioremediation and environmental cleanup of chemical contaminants of concern (COCs)
MARKETING EXPERIENCE: HEALTH, FOOD, BIOSECURITY & ENVIRONMENT
  • Environmental biosecurity threat detection
  • Bioremediation and environmental cleanup of chemical contaminants of concern (COCs)
  • Infectious disease vector control using genetic engineering technologies
  • Vaccines and therapeutics
  • Sustainable food and protein production using gene editing and genetic engineering technologies
Specialized fields and disciplines
  • Biotechnology Development
  • Biopharma
  • Medical Device and Healthcare Technologies
  • Synthetic Biology and Genetic Engineering
  • Public Health
  • Global Health
  • Epidemiology
  • Biodefense and Biosecurity
  • Environmental Health
  • One Health
Specialized fields and disciplines
  • Biotechnology Development
  • Biopharma
  • Medical Device and Healthcare Technologies
  • Synthetic Biology and Genetic Engineering
  • Public Health
  • Global Health
  • Epidemiology
  • Biodefense and Biosecurity
  • Environmental Health
  • One Health
Learn more about my MISSION and CURRENT INITIATIVES
Learn more about my MISSION and CURRENT INITIATIVES